NO20000122L - FremgangsmÕte for fremstilling av kalsiumpyruvater - Google Patents

FremgangsmÕte for fremstilling av kalsiumpyruvater

Info

Publication number
NO20000122L
NO20000122L NO20000122A NO20000122A NO20000122L NO 20000122 L NO20000122 L NO 20000122L NO 20000122 A NO20000122 A NO 20000122A NO 20000122 A NO20000122 A NO 20000122A NO 20000122 L NO20000122 L NO 20000122L
Authority
NO
Norway
Prior art keywords
calcium
pyruvates
obesity
preparation
calcium pyruvates
Prior art date
Application number
NO20000122A
Other languages
English (en)
Other versions
NO20000122D0 (no
Inventor
Ivo Pischel
Stefan Weiss
Guenter Ortenburger
Harro Koenig
Original Assignee
Sueddeutsche Kalkstickstoff
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19729786A external-priority patent/DE19729786A1/de
Application filed by Sueddeutsche Kalkstickstoff filed Critical Sueddeutsche Kalkstickstoff
Publication of NO20000122D0 publication Critical patent/NO20000122D0/no
Publication of NO20000122L publication Critical patent/NO20000122L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/185Saturated compounds having only one carboxyl group and containing keto groups
    • C07C59/19Pyruvic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/41Preparation of salts of carboxylic acids
    • C07C51/412Preparation of salts of carboxylic acids by conversion of the acids, their salts, esters or anhydrides with the same carboxylic acid part

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Nutrition Science (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Catalysts (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)

Abstract

Det beskrives en fremgangsmåte for fremstilling av kalsiumpyruvater, hvorved man omsetter kalsiumsalter av organiske syrer eller sure organiske keto- eller hydroksyforbindelser med pyrodruesyre i temperaturområdet fra -20 til +120°C, eventuelt i nærvær av et fortynnings- eller oppløsningsmiddel. På denne måten er det mulig å fremstille kalsiumpyruvater med høy renhet som stort sett er vannfrie og som utviser en meget god lagringsstabilitet. Disse kalsiumpyruvatene anvendes for å øke utholdenheten og styrke i sporten, for å redusere vekts- og kroppsfett, så vel som beskyttelsessubstans for kroppsceller og vev, som substans for å inhibere radikaldannelsen så vel som radikalinnfangersubstans i kroppsceller og vev, innen medisin, ved behandlingen av fedme og overvekt og som emæringstilskudd.
NO20000122A 1997-07-11 2000-01-10 FremgangsmÕte for fremstilling av kalsiumpyruvater NO20000122L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19729786A DE19729786A1 (de) 1997-07-11 1997-07-11 Verfahren zur Herstellung von Calciumpyruvaten
US08/955,838 US5962734A (en) 1997-07-11 1997-10-21 Method of producing calcium pyruvates
PCT/EP1998/004089 WO1999002479A1 (de) 1997-07-11 1998-07-02 Verfahren zur herstellung von calciumpyruvaten

Publications (2)

Publication Number Publication Date
NO20000122D0 NO20000122D0 (no) 2000-01-10
NO20000122L true NO20000122L (no) 2000-01-10

Family

ID=26038228

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20000122A NO20000122L (no) 1997-07-11 2000-01-10 FremgangsmÕte for fremstilling av kalsiumpyruvater

Country Status (17)

Country Link
EP (1) EP0993433B1 (no)
JP (1) JP2002507998A (no)
AT (1) ATE232195T1 (no)
AU (1) AU725505B2 (no)
BR (1) BR9810702A (no)
CA (1) CA2296017A1 (no)
DK (1) DK0993433T3 (no)
ES (1) ES2189216T3 (no)
HU (1) HUP0004638A3 (no)
IL (1) IL133905A0 (no)
NO (1) NO20000122L (no)
NZ (1) NZ501771A (no)
PL (1) PL337946A1 (no)
SK (1) SK180799A3 (no)
TR (1) TR200000018T2 (no)
TW (1) TW404833B (no)
WO (1) WO1999002479A1 (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20010204A1 (it) * 2001-02-02 2002-08-02 Hunza Di Marazzita Maria Carme Specialita' terapeutiche dotate di attivita' antiossidante ed in grado di controllare l'eccesso del peso corporeo
JP5406643B2 (ja) * 2008-09-22 2014-02-05 日本合成化学工業株式会社 α−オキソカルボン酸の金属塩の製造方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1465432A (fr) * 1965-08-25 1967-01-13 D Opochimiotherapie Lab Nouveau sel de calcium et son procédé de préparation
US5294641A (en) * 1991-11-27 1994-03-15 Montefiore - University Hospital Method for treating a medical patient for cardiac trauma
US5395822A (en) * 1993-09-20 1995-03-07 Izumi; Yukitoshi Use of pyruvate to prevent neuronal degeneration associated with ischemia
US5612374A (en) * 1994-02-14 1997-03-18 Ronald T. Stanko Inhibiting growth of mammary adenocarcinoma
US5480909A (en) * 1994-08-08 1996-01-02 University Of Pittsburgh Medical Center Method for inhibiting generation of free-radicals
AT403916B (de) * 1996-03-11 1998-06-25 Chemie Linz Gmbh Verfahren zur herstellung von calziumpyruvat und dessen hydraten
GB9611356D0 (en) * 1996-05-31 1996-08-07 Howard Alan N Improvements in or relating to compositions containing Creatine, and other ergogenic compounds
US5716926A (en) * 1996-07-26 1998-02-10 Paxton K. Beale Composition of pyruvate and protein and method for increasing protein concentration in a mammal
US5756469A (en) * 1996-07-26 1998-05-26 Beale; Paxton K. Composition of pyruvate and anti-cortisol compounds and method for increasing protein concentration in a mammal

Also Published As

Publication number Publication date
CA2296017A1 (en) 1999-01-21
AU725505B2 (en) 2000-10-12
EP0993433B1 (de) 2003-02-05
NO20000122D0 (no) 2000-01-10
JP2002507998A (ja) 2002-03-12
HUP0004638A1 (hu) 2001-04-28
IL133905A0 (en) 2001-04-30
ATE232195T1 (de) 2003-02-15
DK0993433T3 (da) 2003-05-26
TW404833B (en) 2000-09-11
AU8731298A (en) 1999-02-08
TR200000018T2 (tr) 2000-07-21
WO1999002479A1 (de) 1999-01-21
SK180799A3 (en) 2001-10-08
ES2189216T3 (es) 2003-07-01
NZ501771A (en) 2000-10-27
PL337946A1 (en) 2000-09-11
HUP0004638A3 (en) 2003-09-29
EP0993433A1 (de) 2000-04-19
BR9810702A (pt) 2000-08-08

Similar Documents

Publication Publication Date Title
US4356183A (en) Antihypertensive 4-thiazolidinecarboxylic acids (pyridyl derivatives)
Tew et al. Synthesis and characterization of phosphocitric acid, a potent inhibitor of hydroxylapatite crystal growth
EP0348203B1 (en) Phenolic thioethers, their production and use
HUT72188A (en) Inhibitors of farnesyl-protein transferase
FI93449B (fi) Menetelmä terapeuttisesti käyttökelpoisten imidatsopyridiini-, imidatsopyrimidiini-, imidatsopyridatsiini- ja imidatsopyratsiinijohdannaisten valmistamiseksi
CH634830A5 (de) Verfahren zur herstellung neuer substituierten aminosaeuren.
WO2004085382A1 (ja) 生体内リン輸送を阻害する化合物およびそれを含んでなる医薬
US5886040A (en) Creatine pyruvate salt with enhanced palatability
de Macédo et al. Synthesis of dipeptide-bound epoxides and α, β-unsaturated amides as potential irreversible transglutaminase inhibitors
NO20000122L (no) FremgangsmÕte for fremstilling av kalsiumpyruvater
DK155732B (da) Analogifremgangsmaade til fremstilling af aminosyrederivater
Wadso et al. Heats of hydrolysis of phenyl acetate and phenyl thiolacetate
US5962734A (en) Method of producing calcium pyruvates
Sternbach Biotin
US20210371459A1 (en) Dimeric peptide inhibitors of apoptosis proteins
PT805817E (pt) Derivados tiol com actividade inibidora da metalopeptidase
SU1491337A3 (ru) Способ получени гетероциклических соединений
NO156408B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive l-prolinderivater.
SU770062A1 (ru) Этиловый эфир -этилдибутилоксивариановой кислоты,ОблАдАющий АНАльгЕТичЕСКОй АКТиВНОСТью
Sato et al. Conversion of Steroidal Alkaloids, Tomatidine and Solasodine into Dihydrosapogenins
RU911881C (ru) N-(п-Сульфамоилфенил)-N @ -(2-оксиэтил)сукциндиамид, про вл ющий противовоспалительную активность
SU1060106A3 (ru) Способ получени оптически активных @ -меркаптоалканоиламинокислот
Weiss et al. Influence of penicillamine and various analogs on matrix-induced bone formation in rats
NO831114L (no) Fremgangsmaate for fremstilling av blodtrykkssenkende midler
RU2021259C1 (ru) Производные амида акриловой кислоты или их соли с органическим или неорганическим основанием, обладающие цитопротекторной и противоязвенной активностью, и состав, обладающий цитопротекторной и противоязвенной активностью

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application